India Glycols

Who are the top shareholders of the India Glycols?

The top shareholder of India Glycols is Kashipur Holdings Limited, owning 50.35%. Other notable shareholders include 50 Foreign Institutional Investors with 2.25%, mutual funds with 0.12%, and individual investors holding 28.68%, with Puneet Bhatia as the largest public shareholder at 1.92%.

The top shareholders of India Glycols include Kashipur Holdings Limited, which holds the largest share at 50.35%. The company is primarily owned by its promoters, with no pledged promoter holdings reported. Additionally, there are 50 Foreign Institutional Investors (FIIs) collectively holding 2.25% of the shares, and mutual funds are represented by 8 schemes with a total holding of 0.12%. The highest public shareholder is Puneet Bhatia, who owns 1.92%. Individual investors collectively hold 28.68% of the company's shares.

how big is India Glycols?

As of Jun 06, India Glycols Ltd has a market capitalization of 5,746.14 Cr, with net sales of 3,768.26 Cr and net profit of 230.92 Cr over the latest four quarters. Shareholder's funds are 2,051.02 Cr, and total assets are valued at 5,616.80 Cr as of Mar'24.

Market Cap: As of Jun 06, India Glycols Ltd has a market capitalization of 5,746.14 Cr, classifying it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the sum of Net Sales is 3,768.26 Cr, and the sum of Net Profit is 230.92 Cr. This data is Consolidated.<BR><BR>Balance Sheet Snapshot: This is Consolidated data for the reporting period of Mar'24. The Shareholder's Funds amount to 2,051.02 Cr, and the Total Assets are valued at 5,616.80 Cr.

What does India Glycols do?

India Glycols Ltd is a mid-cap company in the commodity chemicals industry, reporting net sales of ₹863 Cr and a net profit of ₹64 Cr for March 2025. Key metrics include a P/E ratio of 25.00, a dividend yield of 0.42%, and a market cap of ₹5,764 Cr.

Overview:<BR>India Glycols Ltd operates in the commodity chemicals industry and is classified as a mid-cap company.<BR><BR>History:<BR>The company was incorporated as UP Glycols Limited and later changed its name to India Glycols Limited in September 1986. The latest quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 863 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 64 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 5,764 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 25.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.42% <BR>Debt-Equity: 0.80 <BR>Return on Equity: 10.24% <BR>Price to Book: 2.59 <BR><BR>Contact Details:<BR>Address: A-1 Industrial Area, Bazpur Road Kashipur Udham Singh Nagar UTT : 244713 <BR>Tel: 91-05947-269000/269500/275320 <BR>Email: compliance.officer@indiaglycols.com <BR>Website: http://www.indiaglycols.com

Has India Glycols declared dividend?

India Glycols Ltd has declared an 80% dividend, amounting to ₹8 per share, with an ex-date of August 21, 2024. The company has shown strong total returns, with a 5-year total return of 569.37%.

India Glycols Ltd has declared an 80% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 80%<BR>- Amount per share: ₹8<BR>- Ex-date: 21 Aug 24<BR><BR>Dividend Yield: 0.42%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 30.59%, with no dividend return, resulting in a total return of 30.59%.<BR><BR>Over the past year, the price return reached 119.32%, with a dividend return of 0.91%, leading to a total return of 120.23%.<BR><BR>In the 2-year period, the price return was 196.39%, with a dividend return of 2.51%, culminating in a total return of 198.9%.<BR><BR>For the 3-year period, the price return stood at 122.96%, with a dividend return of 3.51%, resulting in a total return of 126.47%.<BR><BR>In the 4-year span, the price return was 234.63%, with a dividend return of 4.82%, leading to a total return of 239.45%.<BR><BR>Finally, over the last 5 years, the price return reached 558.85%, with a dividend return of 10.52%, resulting in a total return of 569.37%.<BR><BR>Overall, India Glycols has declared a significant dividend while also demonstrating strong total returns across various periods, indicating a positive financial performance.

Who are the peers of the India Glycols?

India Glycols' peers include Tata Chemicals, Chemplast Sanmar, GHCL, and others. It has the highest 1-year return at 150.38%, while Gujarat Alkalies has the lowest at -25.63%.

Peers: The peers of India Glycols are Tata Chemicals, Chemplast Sanmar, GHCL, Fischer Medical, Gujarat Alkalies, Grauer & Weil, Tanfac Inds., Thirumalai Chem., Blue Pearl Agri, and J.G.Chemicals.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Chemplast Sanmar, while Average management risk is found at Tata Chemicals, India Glycols, Grauer & Weil, Tanfac Inds., Thirumalai Chem., and J.G.Chemicals. Below Average management risk is noted at Fischer Medical and Gujarat Alkalies. For Growth, Excellent growth is seen at Tanfac Inds., while Below Average growth is present at Tata Chemicals, Chemplast Sanmar, India Glycols, GHCL, Fischer Medical, Gujarat Alkalies, Grauer & Weil, Thirumalai Chem., and J.G.Chemicals. The Capital Structure is Excellent for GHCL, Gujarat Alkalies, and Tanfac Inds., Average for Tata Chemicals, India Glycols, Thirumalai Chem., and Grauer & Weil, and Below Average for Chemplast Sanmar and Fischer Medical.<BR><BR>Return Snapshot: India Glycols has the highest 1-year return at 150.38%, while Gujarat Alkalies has the lowest at -25.63%. Compared to its peers, India Glycols' return is significantly higher. Additionally, the peers with negative six-month returns include Tata Chemicals, Gujarat Alkalies, Grauer & Weil, and Thirumalai Chem.

Who are in the management team of India Glycols?

As of March 2023, the management team of India Glycols includes U S Bhartia (Chairman/Executive Director), Pragya Bhartia Barwale, Sudhir Agarwal (both Executive Directors), and several Independent Non-Executive Directors, ensuring a diverse governance structure.

As of March 2023, the management team of India Glycols includes the following individuals:<BR><BR>1. U S Bhartia - Chairman / Executive Director<BR>2. Jayshree Bhartia - Non Executive Director<BR>3. Pragya Bhartia Barwale - Executive Director<BR>4. Sudhir Agarwal - Executive Director<BR>5. Pradip Kumar Khaitan - Independent Non Executive Director<BR>6. Jitender Balakrishnan - Independent Non Executive Director<BR>7. Ravi Jhunjhunwala - Independent Non Executive Director<BR>8. Jagmohan N Kejriwal - Independent Non Executive Director<BR>9. Sajeve Deora - Independent Non Executive Director<BR>10. Shukla Wassan - Independent Non Executive Director<BR><BR>This team comprises a mix of executive and independent directors, contributing to the governance and strategic direction of the company.

When is the next results date for India Glycols?

India Glycols will announce its results on 07 August 2025.

India Glycols will declare its results on 07 August 2025.

Are India Glycols latest results good or bad?

India Glycols' latest results are generally positive, with record net sales and profit growth; however, rising interest expenses and declining liquidity raise concerns about its financial health.

India Glycols has reported its latest financial results for the quarter ending June 2025, and the overall performance can be viewed positively. The company achieved net sales of Rs 1,040.46 crore, which is the highest quarterly sales in the last five quarters, indicating a strong recovery. Additionally, the operating profit reached Rs 149.64 crore, also marking a peak for the same period. <BR><BR>Profit Before Tax (PBT) increased by 28.4% compared to the average of the previous four quarters, and Profit After Tax (PAT) rose by 26.9%. These figures reflect a solid upward trend in profitability, with quarterly growth rates of 20.53% in net sales and 14.42% in net profit compared to the previous quarter.<BR><BR>However, there are challenges to consider. The interest expense has risen significantly, indicating higher borrowing costs, and cash and cash equivalents have decreased to their lowest level in six half-yearly periods, which raises concerns about short-term liquidity. Additionally, the debt-equity ratio has increased, suggesting a greater reliance on debt for funding operations.<BR><BR>In summary, while India Glycols has delivered strong sales and profit growth, the rising interest expenses and declining liquidity are factors that could impact its financial health moving forward.

Is India Glycols overvalued or undervalued?

As of August 8, 2025, India Glycols is considered overvalued with a PE ratio of 22.10, despite outperforming the Sensex with a 34.57% year-to-date return, as it has moved from a fair to an expensive valuation grade compared to its peers.

As of 8 August 2025, India Glycols has moved from a fair to an expensive valuation grade. The company is currently considered overvalued based on its key financial ratios. The PE ratio stands at 22.10, while the Price to Book Value is 2.39, and the EV to EBITDA is 13.46. These ratios indicate a premium valuation compared to its peers.<BR><BR>In comparison to its industry peers, India Glycols' PE ratio is significantly lower than Solar Industries at 103.57 and Gujarat Fluoroch at 61.32, both categorized as very expensive. However, it is higher than Godrej Industries, which is rated attractive with a PE of 37.72. The company's recent stock performance has outpaced the Sensex, with a year-to-date return of 34.57% compared to the Sensex's 2.20%, but this does not alter the overall assessment of its current valuation.

Is India Glycols technically bullish or bearish?

As of 9 October 2025, the trend has shifted to bullish with moderate strength, supported by bullish daily moving averages and positive Bollinger Bands, although caution is advised due to mildly bearish weekly MACD and KST indicators.

As of 9 October 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with moderate strength. Key indicators supporting this include the daily moving averages being bullish and both the weekly and monthly Bollinger Bands indicating bullish momentum. However, the weekly MACD and KST are mildly bearish, suggesting some caution. The overall performance metrics show strong returns compared to the Sensex, particularly over longer time frames, reinforcing the bullish outlook.

How has been the historical performance of India Glycols?

India Glycols has shown significant growth in net sales and profits, with net sales increasing from 2,316.99 Cr in Mar'21 to 3,768.26 Cr in Mar'25, and profit after tax rising from 129.67 Cr to 184.52 Cr in the same period, despite rising raw material costs. The company's operating profit margin improved to 13.56% in Mar'25, reflecting its strong financial performance.

Answer:<BR>The historical performance of India Glycols shows a significant upward trend in net sales and profit over the years, with the latest figures indicating a robust growth trajectory.<BR><BR>Breakdown:<BR>India Glycols has demonstrated a consistent increase in net sales, rising from 2,316.99 Cr in Mar'21 to 3,768.26 Cr in Mar'25. This growth is accompanied by a rise in total operating income, which reached 3,768.26 Cr in Mar'25, up from 2,650.86 Cr in Mar'23. The company's operating profit (PBDIT) also improved, reaching 525.49 Cr in Mar'25, compared to 319.42 Cr in Mar'23. Profit before tax increased to 245.92 Cr in Mar'25 from 153.63 Cr in Mar'23, while profit after tax rose to 184.52 Cr from 129.67 Cr in the same period. Despite fluctuations in expenses, including a notable increase in raw material costs, the operating profit margin improved to 13.56% in Mar'25 from 11.15% in Mar'23. The total assets of the company grew to 6,176.10 Cr in Mar'25, up from 4,858.33 Cr in Mar'23, while total liabilities also increased to 6,176.10 Cr from 4,858.33 Cr. Cash flow from operating activities was strong at 362.00 Cr in Mar'25, although the company faced a net cash outflow of 20.00 Cr. Overall, India Glycols has shown resilience and growth in its financial performance over the years.

Which are the latest news on India Glycols?

Should I buy, sell or hold India Glycols Ltd?

Why is India Glycols Ltd falling/rising?

As of 02-Feb, India Glycols Ltd's stock price is at 868.00, down 1.58% after a trend reversal. Despite a strong annual return of 31.52%, recent performance is negative, with concerns about weak fundamentals and high debt impacting investor interest.

As of 02-Feb, India Glycols Ltd's stock price is falling, currently at 868.00, reflecting a decrease of 13.9 points or 1.58%. This decline follows a trend reversal after four consecutive days of gains. The stock has underperformed its sector by 1.56% today and reached an intraday low of Rs 842.7, which is a significant drop of 4.44%. <BR><BR>Investor participation has also decreased, with delivery volume falling by 1.78% against the five-day average, indicating reduced interest from investors. Additionally, while the stock has shown strong performance over the past year with a return of 31.52%, its year-to-date performance is down by 14.81%, suggesting a more recent negative trend. <BR><BR>Despite positive financial results in the last three quarters, including a 25.63% growth in profit after tax, the long-term fundamentals appear weak, with an average return on capital employed (ROCE) of only 8.55% and a high debt to EBITDA ratio of 3.21 times. These factors may contribute to the stock's current decline, as they reflect concerns about the company's ability to sustain growth and manage debt effectively.